Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that Janssen Biotech, Inc. (“Janssen”)…
pthomsonDecember 3, 2021
Propionibacterium acnes, though generally considered part of the normal flora of human skin, is an…
pthomsonDecember 2, 2021
Dr. Peter Stirling (Stirling Lab) and co-principal investigators Dr. David Huntsman (Huntsman Lab), Dr. Philip…
pthomsonDecember 2, 2021
At the invitation of Canada School of Public Service, Dr. Carolina Tropini, CIFAR fellow and…
pthomsonDecember 1, 2021
Researchers at the Vancouver Prostate Centre (VPC) have engineered the fastest, artificial intelligence (AI)-enabled technology…
pthomsonDecember 1, 2021
Dr. Nika Shakiba (pictured), Assistant Professor of Biomedical Engineering at UBC, received a SickKids -…
pthomsonDecember 1, 2021
The Honourable Jean-Yves Duclos, Minister of Health, today announced a joint investment of $20 million…
pthomsonNovember 30, 2021
A professor at the University of British Columbia, where he is director of the Centre…
sciencecityJune 14, 2017
“The great thing about working with both patients and pre-clinical models is that the research…
sciencecityJune 13, 2017
How do pathogenic bacteria manipulate host cells and cause disease? What molecular structures allow them…
sciencecityJune 9, 2017
Today Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus”) a specialty pharmaceutical company with expertise…
sciencecityJune 8, 2017
Today Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus”) a specialty pharmaceutical company with expertise…
mjoyJune 8, 2017
Simon Fraser University researchers are investigating why some older Canadians living with multiple chronic health…
sciencecityJune 7, 2017
Orkla Food Ingredients has inked a deal with Canada's Renaissance BioScience to exclusively produce and…
sciencecityJune 6, 2017
